| View |
|
DRP-12407-06
|
Cefalexin (as monohydrate)
|
Ceplegen
|
125 mg/5 mL
|
Powder for Suspension
|
Antibacterial (First Generation Cephalosporin)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
18 November 2022
|
21 July 2027
|
| View |
|
DRP-5216-03
|
Pioglitazone (As Hydrochloride)
|
Poglavit
|
30 mg
|
Tablet
|
Oral Hypoglycemic
|
Medley Pharmaceutical Limited
|
India
|
Automatic Renewal
|
16 November 2022
|
08 July 2028
|
| View |
|
DRP-9242-04
|
Cassia angustifolia Vahl (Senna Leaves and Pods)
|
Fitmeed
|
1.275g/0.425g per Tea Bag
|
|
Laxative
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
16 November 2022
|
20 October 2027
|
| View |
|
DRP-4089-02
|
Ondansetron (as hydrochloride)
|
Asetron
|
2 mg/mL (4 mg/2 mL)
|
Solution for Injection (IM/IV)
|
Serotonin (5HT3) Antagonist
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
15 November 2022
|
08 November 2027
|
| View |
|
DRP-1475-04
|
Amoxicillin (as Trihydrate)
|
Mox-S
|
500 mg
|
Capsule
|
-
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
17 November 2022
|
10 May 2027
|
| View |
|
DRP-8248-01
|
Citicoline (as sodium)
|
Unbranded
|
1 g
|
Film-Coated Tablet
|
Cerebroprotective/Neurotropic
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
11 August 2024
|
03 September 2029
|
| View |
|
DRP-10088-02
|
Nicardipine Hydrochloride
|
Retacard
|
1 mg/mL
|
Solution for IV Infusion
|
-
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
CLIDP Conversion
|
17 November 2022
|
15 May 2025
|
| View |
|
DRP-10246-04
|
Ceftriaxone (as sodium)
|
Frixo
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
17 November 2022
|
01 October 2026
|
| View |
|
DRP-10734-01
|
Ursodeoxycholic Acid
|
Urxyl
|
250 mg
|
Capsule
|
-
|
Mepro Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
17 November 2022
|
21 July 2025
|
| View |
|
DRP-11411-01
|
Multivitamins
|
Boostervit
|
Ascorbic Acid 500 mg,
Thiamine Mononitrate (Vitamin B1) 50 mg,
Niacinamide (Vitamin B3) 50 mg,
Riboflavin (Vitamin B2) 20 mg,
Calcium Pantothenate (Vitamin B5) 20 mg,
Pyridoxine Hydrochloride (Vitamin B6) 5 mg,
Cyanocobalamin (Vitamin B12) 5 mcg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
16 November 2022
|
09 March 2027
|
| View |
|
DRP-12384-01
|
Multivitamins
|
Boostervit
|
Ascorbic Acid (Vitamin C) 500 mg,
Thiamine Mononitrate (Vitamin B1) 50 mg,
Nicotinamide (Vitamin B3) 50 mg,
Riboflavin (Vitamin B2) 20 mg,
Calcium Pantothenate (Vitamin B5) 20 mg,
Pyridoxine HCl (Vitamin B6) 5 mg,
Cyanocobalamin (Vitamin B12) 5 mcg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
16 November 2022
|
29 July 2027
|
| View |
|
DRP-7074-09
|
Meropenem (as trihydrate)
|
Retapenem
|
1 g
|
Powder for Injection (IV)
|
-
|
Daffodills Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
15 November 2022
|
06 March 2027
|
| View |
|
DRP-10166-01
|
Oxaliplatin
|
OxaliGet
|
2 mg/mL (50 mg/25 mL)
|
Concentrate Solution for IV Infusion
|
-
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
15 November 2022
|
06 October 2026
|
| View |
|
DRP-11847-03
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Zitamet Plus
|
50 mg/ 1 g
|
Film-Coated Tablet
|
-
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
15 November 2022
|
10 May 2027
|
| View |
|
DRP-3228-05
|
Mefenamic Acid
|
Mefesus
|
50 mg/5 mL
|
Suspension
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
15 November 2022
|
06 September 2026
|
| View |
|
DRP-5460-05
|
Metronidazole
|
Retazol
|
5mg/mL (500mg/100 mL)
|
Solution for I.V. Infusion
|
Antibacterial (Nitroimidazole) / Antiprotozoal (Amebicide)
|
Shijiazhuang No.4 Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
29 May 2023
|
31 July 2028
|
| View |
|
DRP-6450-19
|
Losartan Potassium + Amlodipine (as besilate)
|
Amloseth Plus
|
50 mg/5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/Calcium Channel Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 November 2022
|
09 December 2025
|
| View |
|
DRP-11813-01
|
Telmisartan + Amlodipine (as besilate)
|
Mistasyl
|
40 mg/ 5 mg
|
Tablet
|
Angiotensin II antagonist/ Calcium Channel Blocker
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
15 November 2022
|
02 May 2027
|
| View |
|
DRP-12392-05
|
Cefalexin (as monohydrate)
|
Raplexin
|
100 mg/mL
|
Powder for Suspension for Oral Drops
|
Antibacterial (First Generation Cephalosporins)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
15 November 2022
|
21 July 2027
|
| View |
|
DRP-12747-01
|
Amlodipine (as Besilate)
|
Odasyl
|
10mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
15 November 2022
|
30 September 2027
|